Abstract
Autoimmune heart diseases in humans are multifactorial and genetically complex. Fortunately a great deal has been learned from animal models. They have established that a variety of infectious or toxic insults can lead to autoimmune heart disease in genetically susceptible animals. These animal models suggest that autoimmune heart disease has multiple etiologies, with differing mechanisms but overlapping genetic determinants culminating in the same end stage inflammatory heart disease. In this review we will focus on autoimmune heart disease caused by two different infectious agents, Trypanosoma cruzi and Coxsackievirus B3. Both pathogens are known to infect the heart and are largely cleared after a brief illness. In certain susceptible individuals, however, a chronic, putative autoimmune attack is initiated. We review the evidence that post infectious chronic myocarditis is indeed autoimmune in nature and discuss our recent findings about the common genetic elements that may predispose to autoimmunity and autoimmune disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Roberts S, Kosanke S, Terrence Dunn S et al. Pathogenic mechanisms in rheumatic carditis: Focus on valvular endothelium. J Infect Dis 2001;183(3):507–511.
Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000;13(3):470–511.
Cunningham MW. Streptococcus-induced myocarditis in mice. Autoimmunity 2001;34(3):193–197.
Engman DM, Leon JS. Pathogenesis of Chagas heart disease: Role of autoimmunity. Acta Trop 2002;81(2):123–132.
Higuchi Mde L, Benvenuti LA, Martins Reis M et al. Pathophysiology of the heart in Chagas’ disease: Current status and new developments. Cardiovasc Res 2003;60(1):96–107.
Hill SL, Rose NR. The transition from viral to autoimmune myocarditis. Autoimmunity 2001;34(3):169–176.
Fairweather D, Kaya Z, Shellam GR et al. From infection to autoimmunity. J Autoimmun 2001;16(3):175–186.
Afanasyeva M, Rose NR. Immune Mediators in inflammatory heart disease: Insights from a mouse model. European Heart Journal 2002;4(Supplement I):131–136.
Noutsias M, Pauschinger M, Poller WC et al. Current insights into the pathogenesis, diagnosis and therapy of inflammatory cardiomyopathy. Heart Fail Monit 2003;3(4):127–135.
O’Connell JB, Bristow MR. Economic impact of heart failure in the United States: Time for a different approach. Journal of Heart and Lung Transplantation 1994;13(4):S107–112.
Brown CA, O’Connell JB. Myocarditis and idiopathic dilated cardiomyopathy. American Journal of Medicine 1995;99(3):309–314.
Drory Y, Turetz Y, Hiss Y et al. Sudden unexpected death in persons less than 40 years of age. American Journal of Cardiology 1991;68(13):1388–1392.
Felker GM, Hu W, Hare JM et al. The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine (Baltimore) 1999;78(4):270–283.
Rose NR, Herskowitz A, Neumann DA et al. Autoimmune myocarditis: A paradigm of post-infection autoimmune disease. Immunology Today 1988;9(4):117–120.
Caforio AL, Goldman JH, Haven AJ et al. Circulating cardiac-specific autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. The Myocarditis Treatment Trial Investigators. European Heart Journal 1997;18(2):270–275.
Caforio AL, Goldman JH, Haven AJ et al. Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives. International Journal of Cardiology 1996;54(2):157–163.
Gauntt CJ, Tracy SM, Chapman N et al. Coxsackievirus-induced chronic myocarditis in murine models. European Heart Journal 1995;16(Suppl 0):56–58.
Wang Y, Afanasyeva M, Hill SL et al. Characterization of murine autoimmune myocarditis induced by self and foreign cardiac myosin. Autoimmunity 1999;31(3):151–162.
Rose NR, Wolfgram LJ, Herskowitz A et al. Postinfectious autoimmunity: Two distinct phases of Coxsackievirus B3-induced myocarditis. Annals of the New York Academy of Sciences 1986;475:146–156.
Reetoo KN, Osman SA, Illavia SJ et al. Quantitative analysis of viral RNA kinetics in Coxsackievirus B3-induced murine myocarditis: Biphasic pattern of clearance following acute infection, with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease. Journal of General Virology 2000;81 (Pt 11):2755–2762.
Rose NR, Neumann DA, Herskowitz A et al. Genetics of susceptibility to viral myocarditis in mice. Pathology and Immunopathology Research 1988;7(4):266–278.
Wolfgram LJ, Beisel KW, Herskowitz A et al. Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice. Journal of Immunology 1986;136(5):1846–1852.
Wolfgram LJ, Beisel KW, Rose NR. Heart-specific autoantibodies following murine Coxsackievirus B3 myocarditis. Journal of Experimental Medicine 1985;161(5):1112–1121.
Neu N, Rose NR, Beisel KW et al. Cardiac myosin induces myocarditis in genetically predisposed mice. Journal of Immunology 1987;139(11):3630–3636.
Neu N, Beisel KW, Traystman MD et al. Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis. Journal of Immunology 1987;138(8):2488–2492.
Lam-Tse WK, Lernmark A, Drexhage HA. Animal models of endocrine/organ-specific autoimmune diseases: Do they really help us to understand human autoimmunity? Springer Semin Immunopathol 2002;24(3):297–321.
Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky’s postulates revisited). Immunol Today 1993;14(9):426–430.
Smith SC, Allen PM. The role of T cells in myosin-induced autoimmune myocarditis. Clinical Immunology and Immunopathology 1993;68(2):100–106.
Smith SC, Allen PM. Myosin-induced acute myocarditis is a T cell-mediated disease. Journal of Immunology 1991;147(7):2141–2147.
dos Santos RR, Rossi MA, Laus JL et al. Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi. J Exp Med 1992;175(1):29–39.
Tarleton RL, Zhang L, Downs MO. “Autoimmune rejection” of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue. Proc Natl Acad Sci USA 1997;94(8):3932–3937.
Leon JS, Godsel LM, Wang K et al. Cardiac myosin autoimmunity in acute Chagas’ heart disease. Infect Immun 2001;69(9):5643–5649.
Beisel KW, Wolfgram L, Hershkowitz A et al. Differences in severity of Coxsackievirus B3-induced myocarditis among H-2 congenic strains. In: Skamane E, ed. Genetic Control of Host Resistance to Infection and Malignancy: Alan R. Liss, Inc., 1985:195–201.
Wilson MGSM, Lubschez R. The familial epidemiology of rheumatic fever. Journal of Pediatrics 1943;22:468–492.
Taranta ATS, Metrakos JD. Rheumatic fever in monozygotic and dizygotic twins. Circulation 1959;20:778–792.
Leng Q, Bentwich Z. Beyond self and nonself: Fuzzy recognition of the immune system. Scand J Immunol 2002;56(3):224–232.
Shevach EM. Regulatory T cells in autoimmmunity*. Annu Rev Immunol 2000;18:423–449.
Rose NR. Infection, mimics, and autoimmune disease. J Clin Invest 2001;107(8):943–944.
Rose NR, Mackay IR. Molecular mimicry: A critical look at exemplary instances in human diseases. Cell Mol Life Sci 2000;57(4):542–551.
Janeway Jr CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197–216.
Traystman MD, Beisel KW. Genetic control of Coxsackievirus B3-induced heart-specific autoantibodies associated with chronic myocarditis. Clinical and Experimental Immunology 1991;86(2):291–298.
Guler ML, Ligons D, Wang Y et al. Two autoimmune diabetes loci influencing T cell apoptosis control susceptibility to experimental autoimmune myocarditis. J Immunol 2005;174(4):216.
Neu N, Craig SW, Rose NR et al. Coxsackievirus induced myocarditis in mice: Cardiac myosin autoantibodies do not cross-react with the virus. Clin Exp Immunol 1987; 69(3):566–574.
Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996;85(3):311–318.
Chang TT, Kuchroo VK, Sharpe AH. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease. Curr Dir Autoimmun 2002;5:113–130.
Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmune diseases-a general susceptibility gene to autoimmunity? Genes Immun 2000;1(3):170–184.
Shevach EM. CD4+ CD25+ suppressor T cells: More questions than answers. Nat Rev Immunol 2002;2(6):389–400.
Tivol EA, Borriello F, Schweitzer AN et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995;3(5):541–547.
Ueda H, Howson JM, Esposito L et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003;423(6939):506–511.
Bergman ML, Penha-Goncalves C, Lejon K et al. Low rate of proliferation in immature thymocytes of the nonobese diabetic mouse maps to the Idd6 diabetes susceptibility region. Diabetologia 2001;44(8):1054–1061.
Bergman ML, Duarte N, Campino S et al. Diabetes protection and restoration of thymocyte apoptosis in NOD Idd6 congenic strains. Diabetes 2003;52(7):1677–1682.
Colucci F, Bergman ML, Penha-Goncalves C et al. Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region. Proc Natl Acad Sci USA 1997;94(16):8670–8674.
Neu N, Ploier B, Ofner C. Cardiac myosin-induced myocarditis. Heart autoantibodies are not involved in the induction of the disease. J Immunol 1990;145(12):4094–4100.
Huber SA, Lodge PA. Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice. Am J Pathol 1986;122(2):284–291.
Liao L, Sindhwani R, Rojkind M et al. Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J Exp Med 1995;181(3):1123–1131.
Kuan AP, Chamberlain W, Malkiel S et al. Genetic control of autoimmune myocarditis mediated by myosin-specific antibodies. Immunogenetics 1999;49(2):79–85.
Kuan AP, Zuckier L, Liao L et al. Immunoglobulin isotype determines pathogenicity in antibody-mediated myocarditis in naive mice. Circ Res 2000;86(3):281–285.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2006 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Guler, M.L., Ligons, D., Rose, N.R. (2006). Genetics of Autoimmune Myocarditis. In: Immunogenetics of Autoimmune Disease. Medical Intelligence Unit. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-39926-3_10
Download citation
DOI: https://doi.org/10.1007/978-0-387-39926-3_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-36004-1
Online ISBN: 978-0-387-39926-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)